CCL27 and neoplasm: In contrast, de Nonneville et al. found there was a survival advantage to ACT in high-risk ER+HER2− ILC, defined as having either macroscopic lymph node involvement, or a tumour size over 20 mm and LVI, but not in low-risk ILC [43], as did Tamirisra et al. [42].